ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked AwayThe Motley Fool • 12/28/25
ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina FranchiseGlobeNewsWire • 12/02/25
ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/25/25
Here's How ANIP's Rare Disease Portfolio Is Driving Top-line GrowthZacks Investment Research • 11/21/25
ANI (ANIP) Loses 15% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 11/19/25
ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – LondonGlobeNewsWire • 11/11/25
Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key MetricsZacks Investment Research • 11/07/25
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/07/25
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 GuidanceGlobeNewsWire • 11/07/25
ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating EstimatesSeeking Alpha • 10/28/25
ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?Zacks Investment Research • 10/27/25
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 10/27/25
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ETGlobeNewsWire • 10/24/25
Will This Drug Stock Explode After Earnings As It Did Last Quarter?Investors Business Daily • 10/22/25
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 MeetingGlobeNewsWire • 10/16/25